• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种药物处置的线性再循环模型。

A linear recirculation model for drug disposition.

作者信息

Cutler D J

出版信息

J Pharmacokinet Biopharm. 1979 Feb;7(1):101-16. doi: 10.1007/BF01059445.

DOI:10.1007/BF01059445
PMID:458553
Abstract

A new approach to the modeling of drug disposition is described. Disposition is regarded as the result of repetitive passes of the drug around the circulation. Mathematical analysis of experimental blood concentration data yields an expression describing the kinetics of a single pass through the tissues. In physicochemical terms the single-pass behavior depends to a large extent on the interaction of the drug with individual tissues, which greatly simplifies interpretation. The method may reveal features of disposition not apparent from experimental blood concentration data.

摘要

本文描述了一种药物处置建模的新方法。处置被视为药物在循环系统中反复通过的结果。对实验血药浓度数据进行数学分析,得出一个描述药物单次通过组织动力学的表达式。从物理化学角度来看,单次通过行为在很大程度上取决于药物与各个组织的相互作用,这大大简化了解释。该方法可能揭示出从实验血药浓度数据中不明显的处置特征。

相似文献

1
A linear recirculation model for drug disposition.一种药物处置的线性再循环模型。
J Pharmacokinet Biopharm. 1979 Feb;7(1):101-16. doi: 10.1007/BF01059445.
2
Theorems and implications of a model independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. I. Derivations and theoretical analysis.线性及部分非线性药物处置的模型无关消除/分布函数分解的定理与推论。I. 推导与理论分析。
J Pharmacokinet Biopharm. 1984 Dec;12(6):627-48. doi: 10.1007/BF01059557.
3
Properties of the recirculation model: matrix description and conditions for a monotonic decreasing single pass response.再循环模型的性质:矩阵描述及单调递减单通道响应的条件
J Pharmacokinet Biopharm. 1981 Apr;9(2):217-23. doi: 10.1007/BF01068083.
4
Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. II. Clearance concepts applied to the evaluation of distribution kinetics.线性及某些非线性药物处置的模型无关消除/分布函数分解的定理及推论。II. 应用于分布动力学评估的清除概念。
J Pharmacokinet Biopharm. 1985 Aug;13(4):441-51. doi: 10.1007/BF01061479.
5
Hemodynamic influences upon the variance of disposition residence time distribution of drugs.血流动力学对药物处置停留时间分布方差的影响。
J Pharmacokinet Biopharm. 1983 Feb;11(1):63-75. doi: 10.1007/BF01061768.
6
Statistical moments in pharmacokinetics.药代动力学中的统计矩
J Pharmacokinet Biopharm. 1978 Dec;6(6):547-58. doi: 10.1007/BF01062109.
7
Model-independent assessment of accumulation kinetics based on moments of drug disposition curves.
Eur J Clin Pharmacol. 1984;27(3):355-9. doi: 10.1007/BF00542175.
8
Moments of physiological transit time distributions and the time course of drug disposition in the body.生理转运时间分布的时刻以及药物在体内处置的时间进程。
J Math Biol. 1982;15(3):305-18. doi: 10.1007/BF00275690.
9
Exponential tails of drug disposition curves: reality or appearance?药物处置曲线的指数尾部:现实还是表象?
J Pharmacokinet Pharmacodyn. 2014 Feb;41(1):49-54. doi: 10.1007/s10928-013-9345-x. Epub 2013 Dec 13.
10
A new method for assessment of drug disposition in muscle: application of statistical moment theory to local perfusion systems.一种评估肌肉中药物处置的新方法:统计矩理论在局部灌注系统中的应用。
J Pharmacokinet Biopharm. 1985 Dec;13(6):609-31. doi: 10.1007/BF01058904.

引用本文的文献

1
Spatio-temporal simulation of first pass drug perfusion in the liver.肝脏首过药物灌注的时空模拟
PLoS Comput Biol. 2014 Mar 13;10(3):e1003499. doi: 10.1371/journal.pcbi.1003499. eCollection 2014 Mar.
2
Exponential tails of drug disposition curves: reality or appearance?药物处置曲线的指数尾部:现实还是表象?
J Pharmacokinet Pharmacodyn. 2014 Feb;41(1):49-54. doi: 10.1007/s10928-013-9345-x. Epub 2013 Dec 13.
3
Physiologically based structure of mean residence time.基于生理学的平均停留时间结构。

本文引用的文献

1
Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.将人体视为具有单室性质进行药代动力学分析时存在的缺点。
J Pharm Sci. 1968 Jan;57(1):117-23. doi: 10.1002/jps.2600570123.
2
Transfer times across the human body.
Bull Math Biophys. 1972 Mar;34(1):33-44. doi: 10.1007/BF02477022.
3
The pharmacokinetics of propylthiouracil.丙硫氧嘧啶的药代动力学。
Acta Pharmacol Toxicol (Copenh). 1974 Nov;35(5):361-9. doi: 10.1111/j.1600-0773.1974.tb00756.x.
ScientificWorldJournal. 2012;2012:610631. doi: 10.1100/2012/610631. Epub 2012 Apr 1.
4
Pharmacokinetic differentiation of drug candidates using system analysis and physiological-based modelling. Comparison of C.E.R.A. and erythropoietin.利用系统分析和基于生理学的建模对候选药物进行药代动力学区分。C.E.R.A.与促红细胞生成素的比较。
J Pharm Pharmacol. 2008 Oct;60(10):1321-34. doi: 10.1211/jpp/60.10.0008.
5
Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts.基于器官清除率、循环和分形概念的高级药代动力学模型。
AAPS J. 2007 Jun 29;9(2):E268-83. doi: 10.1208/aapsj0902030.
6
A recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference.一种通过测量门静脉和体循环血液浓度差异来建立肝肠循环的再循环模型。
J Pharmacokinet Pharmacodyn. 2003 Apr;30(2):119-44. doi: 10.1023/a:1024415730100.
7
Properties of the recirculation model: calculation of the amount of drug in the body from blood concentration data, with application to absorption rate calculations.再循环模型的特性:根据血药浓度数据计算体内药物量,并应用于吸收速率计算。
J Pharmacokinet Biopharm. 1981 Apr;9(2):225-34. doi: 10.1007/BF01068084.
8
Properties of the recirculation model: matrix description and conditions for a monotonic decreasing single pass response.再循环模型的性质:矩阵描述及单调递减单通道响应的条件
J Pharmacokinet Biopharm. 1981 Apr;9(2):217-23. doi: 10.1007/BF01068083.
9
Moments of physiological transit time distributions and the time course of drug disposition in the body.生理转运时间分布的时刻以及药物在体内处置的时间进程。
J Math Biol. 1982;15(3):305-18. doi: 10.1007/BF00275690.
10
Altered disposition and availability of cimetidine in liver cirrhotic patients.肝硬化患者中西咪替丁的处置和可用性改变。
Br J Clin Pharmacol. 1982 Sep;14(3):421-30. doi: 10.1111/j.1365-2125.1982.tb02002.x.
4
Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses.
J Pharmacokinet Biopharm. 1975 Jun;3(3):181-92. doi: 10.1007/BF01067907.
5
Pharmocokinetics of hexobarbital in man after intravenous infusion.
J Pharmacokinet Biopharm. 1975 Feb;3(1):1-11. doi: 10.1007/BF01066591.
6
Physiologically based pharmacokinetic model for digoxin disposition in dogs and its preliminary application to humans.
J Pharm Sci. 1977 Dec;66(12):1679-83. doi: 10.1002/jps.2600661206.
7
Linear systems analysis in pharmacokinetics.
J Pharmacokinet Biopharm. 1978 Jun;6(3):265-82. doi: 10.1007/BF01312266.